Understanding how lipids activate LC3-associated phagocytosis
LC3-associated phagocytosis (LAP) is a specialized process for degrading dead cells, microbes or other particles. It plays a…
New PET tracer enables rapid imaging of aggressive breast and bladder cancers
A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial…
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…
Abnormal protein activity found to promote cell migration and spread of glioblastoma
Ever wondered how the different cells in our body communicate with each other to fulfill their different roles-be…
New tool can predict where deadly brain cancer might reappear
Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but…
NYU Langone strengthens world-leading GI cancer program with renowned leaders
NYU Langone Health’s Perlmutter Cancer Center announces the arrival of acclaimed cancer leaders Anirban Maitra, MD, and Manuel…
Platelets found to mop up DNA fragments and improve early cancer detection
Platelets are probably best known for their role in blood clotting, making scabs and related, if less salubrious,…
Genomic clues uncover early origins of multiple myeloma
A new study maps out the timeline of DNA damage for multiple myeloma, the second most common blood…
Scientists discover molecular brake that limits T cell attack on tumors
In a discovery that could expand the array of current cancer immunotherapy treatments, scientists at Harvard Medical School…
Multi-analyte test accurately identifies brain cancers using small cerebrospinal fluid
A novel, multi-analyte test developed by researchers at the Johns Hopkins Kimmel Cancer Center, its Ludwig Center and…
Diabetes-altered blood particles suppress immune defense in breast cancer
People with type 2 obesity-driven diabetes tend to have more aggressive breast cancers, but no one knows exactly…
ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation
Background and aims Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of…